Zynerba Pharmaceuticals Price on November 13, 2023

Zynerba Pharmaceuticals Valuation on November 13, 2023

Zynerba Pharmaceuticals Trading Date Momentum on November 13, 2023

On November 27 2024 Zynerba Pharmaceuticals was traded for  0.36  at the closing time. The top price for the day was 0.38  and the lowest listed price was  0.36 . There was no trading activity during the period 0.0. Lack of trading volume on November 27, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 2.78% .

Zynerba Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Zynerba Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zynerba Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zynerba financial account trend analysis is a perfect complement when working with valuation or volatility modules.

Zynerba Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zynerba is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zynerba Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zynerba Pharmaceuticals stock prices may prove useful in developing a viable investing in Zynerba Pharmaceuticals

Zynerba Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how Zynerba Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zynerba Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zynerba Pharmaceuticals stock market strength indicators, traders can identify Zynerba Pharmaceuticals entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for Zynerba Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zynerba Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zynerba to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.